|
C18ORF25 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.3836999999991E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.34959999999962E-05 |
| Normal-vs-Stage2 |
1.194100E-02 |
| Normal-vs-Stage3 |
4.055300E-03 |
| Normal-vs-Stage4 |
3.409500E-02 |
| Stage1-vs-Stage2 |
5.269000E-01 |
| Stage1-vs-Stage3 |
7.075400E-01 |
| Stage1-vs-Stage4 |
5.576200E-01 |
| Stage2-vs-Stage3 |
4.431600E-01 |
| Stage2-vs-Stage4 |
3.023200E-01 |
| Stage3-vs-Stage4 |
7.405200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.01089999998894E-06 |
| Normal-vs-AfricanAmerican |
5.955600E-03 |
| Normal-vs-Asian |
4.0397999999997E-05 |
| Caucasian-vs-AfricanAmerican |
4.468000E-01 |
| Caucasian-vs-Asian |
2.964000E-02 |
| AfricanAmerican-vs-Asian |
1.306050E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.67049999949742E-07 |
| Normal-vs-Female |
6.829800E-02 |
| Male-vs-Female |
1.458150E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.580400E-02 |
| Normal-vs-Extreme_Weight |
2.11179999998201E-06 |
| Normal-vs-Obese |
9.365800E-04 |
| Normal-vs-Extreme_Obese |
3.076600E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.758050E-01 |
| Normal_Weight-vs-Obese |
7.523600E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.890600E-01 |
| Extreme_Weight-vs-Obese |
2.064600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.691000E-01 |
| Obese-vs-Extreme_Obese |
5.910800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.372770E-01 |
| Normal-vs-Age(41-60Yrs) |
9.437000E-03 |
| Normal-vs-Age(61-80Yrs) |
1.86479999997324E-07 |
| Normal-vs-Age(81-100Yrs) |
4.05270000003455E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.582400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.813790E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.751900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.132000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.850000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.099200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.66880000000269E-05 |
| Normal-VS-Type2 PRCC |
1.68909999999078E-05 |
| Normal-VS-KIRP CIMP |
5.842000E-02 |
| Normal-VS-Unclassified PRCC |
3.159600E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.535820E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.997400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.080000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.462400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.656800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.407200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.5683999998739E-07 |
| Normal-vs-N1 |
5.574900E-04 |
| Normal-vs-N2 |
3.759800E-03 |
| N0-vs-N1 |
6.777000E-01 |
| N0-vs-N2 |
6.558800E-01 |
| N1-vs-N2 |
5.689800E-01 |
|
|
